Amount | Holding |
---|---|
2.04% | KBR Inc |
2.03% | Bristol-Myers Squibb Company |
2.02% | DaVita Inc |
2.02% | Microsoft Corp |
1.99% | Molina Healthcare Inc |
1.95% | Teradyne Inc |
1.95% | Tetra Tech Inc |
1.91% | General Mills Inc |
Expense Ratio Rating
3 /10
Expense Rating
0 /10
Market Score
7 /10
Category Score
0 /10
Market Size
7 /10
Glenmede Quantitative U.S. Long/Short Equity Portfolio
Expenses: 2.43% (Better than 0% of similar funds)
This is a bad choice for a Short Alternatives fund. See why »
Amount | Holding |
---|---|
2.04% | KBR Inc |
2.03% | Bristol-Myers Squibb Company |
2.02% | DaVita Inc |
2.02% | Microsoft Corp |
1.99% | Molina Healthcare Inc |
1.95% | Teradyne Inc |
1.95% | Tetra Tech Inc |
1.91% | General Mills Inc |
Minafi - The intersection of FI, minimalism & mindfulness.
Don't miss out on new posts, courses, interactive articles and more!
Join & Get Your First Course Free© 2025 Adam Fortuna
Site Map